Alkermes (ALKS) Tops Q2 EPS by 2c; updates guidance
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Price: $46.10 -1.66%
Revenue Growth %: +17.7%
Financial Fact:
Other income (expense), net: -195K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +17.7%
Financial Fact:
Other income (expense), net: -195K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q2 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $496.01 million versus the consensus estimate of $458.98 million.
GUIDANCE:
Alkermes sees FY2026 revenue of $1.73-1.84 billion, versus the consensus of $1.81 billion.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
